Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 23293697)

Published in Curr Cardiovasc Risk Rep on September 25, 2012

Authors

Sheela N Magge1

Author Affiliations

1: Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia; Perelman School of Medicine at the University of Pennsylvania.

Articles cited by this

(truncated to the top 100)

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59

Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28

Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85

10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52

Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med (1998) 15.09

Obesity and the metabolic syndrome in children and adolescents. N Engl J Med (2004) 13.99

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med (2003) 8.54

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37

Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics (2011) 7.30

The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics (2006) 7.19

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96

Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol (1997) 6.80

Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med (2006) 6.71

Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA (2003) 6.60

Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care (2000) 6.21

Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med (2003) 5.87

Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol (1996) 4.92

Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr (1996) 4.84

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol (1987) 4.27

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation (1990) 3.83

Adiponectin and protection against type 2 diabetes mellitus. Lancet (2003) 3.79

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA (2004) 3.69

Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA (1999) 3.69

National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics (1992) 3.68

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 3.57

Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation (2002) 3.49

Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension (2009) 3.22

Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care (2006) 3.16

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation (2006) 3.00

Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet (2000) 2.92

Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89

Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet (2001) 2.88

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J (2006) 2.87

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes (2003) 2.79

Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab (2004) 2.74

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res (1999) 2.59

Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care (2007) 2.38

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation (2004) 2.22

Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr (2009) 2.21

Pathogenesis of type 2 diabetes mellitus. Arch Med Res (2005) 2.18

Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation (2004) 2.11

Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care (2006) 2.09

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care (2005) 2.07

Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension (2003) 2.06

Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) (2006) 2.05

Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab (2004) 2.03

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab (2009) 2.01

Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol (2006) 2.00

American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics (1992) 1.99

Leptin and atherosclerosis. Atherosclerosis (2006) 1.95

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.95

Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol (2004) 1.92

Reference values of pulse wave velocity in healthy children and teenagers. Hypertension (2010) 1.91

Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics (2006) 1.85

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes (2010) 1.80

Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes (2002) 1.78

Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care (2004) 1.75

The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab (2005) 1.74

Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res (2003) 1.72

PAI-1 and atherothrombosis. J Thromb Haemost (2005) 1.71

Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation (1995) 1.66

Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes. J Pediatr (2000) 1.65

Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years. J Pediatr (2010) 1.64

Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation (2004) 1.62

Cardiovascular impact of the pediatric obesity epidemic: higher left ventricular mass is related to higher body mass index. J Pediatr (2010) 1.60

Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation (2004) 1.58

Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care (2003) 1.58

Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth. J Pediatr (2012) 1.57

Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med (2003) 1.55

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study. Circulation (2005) 1.50

Adiponectin: from obesity to cardiovascular disease. Obes Rev (2009) 1.50

Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr (2004) 1.50

Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med (2007) 1.49

Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care (2003) 1.43

Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care (2005) 1.43

Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study. J Pediatr (2010) 1.43

Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab (2007) 1.42

The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord (2004) 1.41

Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr (2005) 1.38

Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care (2010) 1.37

Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J (2003) 1.30

Diabetic macrovascular disease: the glucose paradox? Circulation (2002) 1.29

Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol (2003) 1.22